Table 5. Correlation Between ACP1 Parameters and LVEF in Patients With CAD.
All patients |
CAD |
Non CAD |
||||
---|---|---|---|---|---|---|
r | P | r | P | r | P | |
Total activity | -0.150 | 0.005 | -0.137 | 0.049 | -0.088 | 0.310 |
S isoform | -0.147 | 0.006 | -0.176 | 0.012 | 0.000 | 0.994 |
F isoform | -0.004 | 0.943 | 0.052 | 0.455 | -0.094 | 0.280 |
F/S ratio | 0.109 | 0.042 | 0.159 | 0.023 | -0.057 | 0.513 |
Patients with CAD |
|||||
---|---|---|---|---|---|
Diabetics |
Non Diabetics |
||||
r | P | r | P | ||
Total activity | -0.247 | 0.039 | -0.022 | 0.805 | |
S isoform | -0.338 | 0.004 | -0.036 | 0.691 | |
F isoform | 0.123 | 0.312 | 0.016 | 0.860 | |
F/S ratio | 0.289 | 0.015 | 0.047 | 0.607 |